Testing effectiveness (Phase 2)UnknownNCT03346811
What this trial is testing
Efficiency of Icotinib in Plasma ctDNA EGFR Mutation-positive Patients Diagnosed With Lung Cancer
Who this might be right for
Plasma EGFR Mutation-positive Lung Cancer
Betta Pharmaceuticals Co., Ltd. 120